Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
BMJ Open|July 23, 2025
Exploring patient and professional perspectives on implementing pharmacogenomic testing in the UK primary care setting and estimating the cost-effectiveness: a mixed-methods study protocolSadaf Qureshi, Asam Latif, Dyfrig A Hughes, et al.
BMJ Open|July 5, 2022
Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissionsRostam Osanlou, Lauren Walker, Dyfrig A Hughes, et al.
British Journal of Clinical Pharmacology|July 27, 2025
Medication adherence during the run-in phase of clinical trials: A systematic review of methodological and reporting rigourNon Davies, Bernard Vrijens, Daniel F B Wright, et al.
Pharmacoeconomics|October 21, 2005
Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux diseaseDyfrig A Hughes, Keith Bodger, Peter Bytzer, et al.
BMJ (Clinical Research Ed.)|March 14, 2007
Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysisRhiannon T Edwards, Alan Céilleachair, Tracey Bywater, et al.
Pharmacoeconomics|March 10, 2018
New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and OutcomesAlice Varnava, Robert Bracchi, Karen Samuels, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2008
Understanding medication compliance and persistence from an economics perspectiveRachel A Elliott, Judith A Shinogle, Pamela Peele, et al.
Epilepsy & Behavior : E&B|March 31, 2015
Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherenceCatrin O Plumpton, Ian Brown, Markus Reuber, et al.
British Journal of Clinical Pharmacology|January 21, 2025
Risk of bias tools for medication adherence research: RoBIAS and RoBOASKlarissa A Sinnappah, Dyfrig A Hughes, Sophie L Stocker, et al.
Clinical Pharmacology and Therapeutics|September 16, 2020
Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug DevelopmentDaniel Hill-McManus, Scott Marshall, Jing Liu, et al.
Pageof 16